Edward M. Newman

Also affiliated with City of Hope

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 11 papers. Top paper: “Effect of Cisplatin and Gemcitabine With or Without Berzosertib in Patients With Advanced Urothelial Carcinoma”.

Effect of Cisplatin and Gemcitabine With or Without Berzosertib in Patients With Advanced Urothelial Carcinoma

JAMA Oncology(2021)10.1001/jamaoncol.2021.3441

N/A

1.6DataRank · unranked

45 citations

Paul Frankel, Amir Mortazavi, Matthew I. Milowsky, Ulka N. Vaishampayan, Mamta Parikh +15 more

Erlotinib and Onalespib Lactate Focused on EGFR Exon 20 Insertion Non-Small Cell Lung Cancer (NSCLC): A California Cancer Consortium Phase I/II Trial (NCI 9878)

Clinical Lung Cancer(2021)10.1016/j.cllc.2021.05.001

N/A

0.789DataRank · unranked

18 citations

Karen L. Reckamp, Paul Frankel, Jeff Longmate, Karen A. Kelly, David R. Gandara +7 more

Osimertinib plus necitumumab in EGFR-mutant NSCLC: Final results from an ETCTN California Cancer Consortium phase I study.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.9014

N/A

0.373DataRank · unranked

11 citations

Mark Krailo, Sukhmani K. Padda, Susan Groshen, Heather A. Wakelee, Karen L. Reckamp +14 more

A phase I study of intravenous fenretinide (4-HPR) for patients with malignant solid tumors

Cancer Chemotherapy and Pharmacology(2021)10.1007/s00280-020-04224-8

N/A

0DataRank · unranked

22 citations

Anthony B. El-Khoueiry, Barry J. Maurer, Susan Groshen, Jacek Pinski, Everardo Cobos +6 more

Order of patient entry and outcomes in phase II clinical trials: A meta-analysis of individual patient data

Contemporary Clinical Trials(2023)10.1016/j.cct.2023.107083

N/A

0DataRank · unranked

0 citations

Miguel A. Villalona‐Calero, Edward M. Newman, Paul Frankel, Carolyn E. Behrendt

A phase 1 study of blinatumomab/lenalidomide in relapsed/refractory B-cell lymphoma: toxicity, efficacy, and correlative analysis

Blood Advances(2025)10.1182/bloodadvances.2025016845

N/A

0DataRank · unranked

2 citations

Tamer Othman, Paul Frankel, Christopher Ruel, Christina Poh, Samantha Herbert +20 more

The ATR Inhibitor Elimusertib in Combination with Cisplatin in Patients with Advanced Solid Tumors: A California Cancer Consortium Phase I Trial (NCI 10404)

Cancer Research Communications(2025)10.1158/2767-9764.crc-25-0305

N/A

0DataRank · unranked

1 citations

Nataliya V. Uboha, Naoko Takebe, Kit Tam, Philippe L. Bédard, Kari B. Wisinski +13 more

Model of a Queuing Approach for Patient Accrual in Phase 1 Oncology Studies

JAMA Network Open(2020)10.1001/jamanetworkopen.2020.4787

N/A

0DataRank · unranked

16 citations

Vincent Chung, Joseph M. Tuscano, Tanya Siddiqi, Sagus Sampath, Jeff Longmate +3 more

A phase 1 study of orally administered 5-fluoro-2’-deoxycytidine with tetrahydrouridine in patients with refractory solid tumors

Cancer Chemotherapy and Pharmacology(2025)10.1007/s00280-025-04844-y

N/A

0DataRank · unranked

1 citations

Shivaani Kummar, Larry Rubinstein, Jennifer Zlott, Geraldine O’Sullivan Coyne, Vincent Chung +17 more

Intravenous 5-fluoro-2′-deoxycytidine administered with tetrahydrouridine increases the proportion of p16-expressing circulating tumor cells in patients with advanced solid tumors

Cancer Chemotherapy and Pharmacology(2020)10.1007/s00280-020-04073-5

N/A

0DataRank · unranked

26 citations

Lihua Wang, Jennifer Zlott, Lamin Juwara, Joseph M. Covey, Jan H. Beumer +18 more

Phase I study of TRC102 in combination with cisplatin and pemetrexed in patients with advanced solid tumors/Phase II study of TRC102 with pemetrexed in patients with mesothelioma refractory to pemetrexed and cisplatin or carboplatin.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.9055

N/A

0DataRank · unranked

1 citations

Paul Frankel, Jonathan W. Riess, Anthony B. El-Khoueiry, Liza C. Villaruz, Stephen Leong +5 more